Johswich K, McCaw S, Strobel L, Frosch M, Gray-Owen S
Infect Immun. 2014; 83(1):354-63.
PMID: 25368118
PMC: 4288889.
DOI: 10.1128/IAI.02495-14.
Le Saux N, Ashton F, Rahman M, Ryan A, Ellis E, Tamblyn S
Can J Infect Dis. 2012; 3(2):60-4.
PMID: 22529733
PMC: 3328020.
DOI: 10.1155/1992/928727.
MacNeil J, Thomas J, Cohn A
Curr Infect Dis Rep. 2011; 13(4):374-9.
PMID: 21603878
DOI: 10.1007/s11908-011-0195-7.
Neil R, Apicella M
Future Microbiol. 2009; 4(5):555-63.
PMID: 19492966
PMC: 2827931.
DOI: 10.2217/fmb.09.27.
Welsch J, Granoff D
Infect Immun. 2004; 72(10):5903-9.
PMID: 15385492
PMC: 517551.
DOI: 10.1128/IAI.72.10.5903-5909.2004.
Characterization of humoral and cellular immune responses elicited by meningococcal carriage.
Robinson K, Neal K, Howard C, Stockton J, Atkinson K, Scarth E
Infect Immun. 2002; 70(3):1301-9.
PMID: 11854214
PMC: 127751.
DOI: 10.1128/IAI.70.3.1301-1309.2002.
Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners.
Marks P, Neal K
BMC Public Health. 2002; 1:16.
PMID: 11806758
PMC: 64787.
DOI: 10.1186/1471-2458-1-16.
Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination.
AlaAldeen D, Neal K, Ait-Tahar K, Nguyen-Van-Tam J, English A, Falla T
J Clin Microbiol. 2000; 38(6):2311-6.
PMID: 10834994
PMC: 86789.
DOI: 10.1128/JCM.38.6.2311-2316.2000.
The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.
Kahler C, Martin L, Shih G, Rahman M, Carlson R, Stephens D
Infect Immun. 1998; 66(12):5939-47.
PMID: 9826376
PMC: 108752.
DOI: 10.1128/IAI.66.12.5939-5947.1998.
Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study.
Kristiansen B, Tveten Y, Jenkins A
BMJ. 1998; 317(7159):621-5.
PMID: 9727987
PMC: 28653.
DOI: 10.1136/bmj.317.7159.621.
Secondary prevention of meningococcal disease.
Kristiansen B, Knapskog A
BMJ. 1996; 312(7031):591-2.
PMID: 8595321
PMC: 2350377.
DOI: 10.1136/bmj.312.7031.591.
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population.
Caugant D, Hoiby E, Magnus P, Scheel O, Hoel T, Bjune G
J Clin Microbiol. 1994; 32(2):323-30.
PMID: 8150942
PMC: 263032.
DOI: 10.1128/jcm.32.2.323-330.1994.
Smoking, the environment and meningococcal disease: a case control study.
Stuart J, Hughes A, Robinson P, Griffin M, Cartwright K
Epidemiol Infect. 1994; 112(2):315-28.
PMID: 8150006
PMC: 2271460.
DOI: 10.1017/s0950268800057733.
Seroepidemiologic aspects of Neisseria meningitidis in homosexual men.
Salit I, Frasch C
Can Med Assoc J. 1982; 126(1):38-41.
PMID: 6800626
PMC: 1862796.
Increased meningococcal carrier rate after tonsillectomy.
Kristiansen B, Elverland H
Br Med J (Clin Res Ed). 1984; 288(6422):974.
PMID: 6423166
PMC: 1442466.
DOI: 10.1136/bmj.288.6422.974.
Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.
Zollinger W, Mandrell R
Infect Immun. 1983; 40(1):257-64.
PMID: 6403466
PMC: 264843.
DOI: 10.1128/iai.40.1.257-264.1983.
Immunological cross-reaction between a naturally occurring galactan, agarose, and an LPS locus for immune lysis of Neisseria meningitidis by human sera.
Griffiss J, Goroff D
Clin Exp Immunol. 1981; 43(1):20-7.
PMID: 6166415
PMC: 1537128.
The meningococcus and mechanisms of pathogenicity.
DeVoe I
Microbiol Rev. 1982; 46(2):162-90.
PMID: 6126800
PMC: 281537.
DOI: 10.1128/mr.46.2.162-190.1982.
Editorial: Meningococcal infections.
Br Med J. 1974; 3(5926):295-6.
PMID: 4213048
PMC: 1611790.
Meningococcal phenotypic and genotypic characteristics and human antibody levels.
Kristiansen B, Lind K, Mevold K, Sorensen B, Froholm L, Bryn K
J Clin Microbiol. 1988; 26(10):1988-92.
PMID: 3141457
PMC: 266803.
DOI: 10.1128/jcm.26.10.1988-1992.1988.
